Increased biologic utilization in Latino patients with psoriasis
| Autor: | Tammy Gonzalez, Alan B. Fleischer |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
030203 arthritis & rheumatology
Biological Products Multivariate analysis business.industry Ethnic group Dermatology Odds ratio Hispanic or Latino medicine.disease Confidence interval 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Psoriasis Health Care Surveys Ambulatory medicine Odds Ratio Population study Humans Severe psoriasis business Demography |
| Zdroj: | The Journal of dermatological treatment. 33(2) |
| ISSN: | 1471-1753 |
| Popis: | Introduction Hispanic/Latino populations are more likely to have extensive psoriasis than the non-Hispanic/Latino population. Biologics are indicated for moderate/severe psoriasis or psoriasis with comorbidities. No studies have assessed ethnicity as a predictor of biologic utilization. We aimed to determine if biologic utilization differs between Latinos and non-Latinos with psoriasis. Methods This study utilizes data from the National Ambulatory Medical Care Survey (NAMCS) from 2003 to 2016. Psoriasis visits were selected by International Classification of Diseases, Ninth or Tenth Revision (ICD-9/ICD-10) classification. The primary outcome is biologic use at the time of visit. Results Of 1202 psoriasis visits, Latinos consisted of 9.7% (95% Confidence Interval 7.3-12) of the study population and 65% (95%CI 61-69) used private insurance. Multivariate analysis reveals the increased likelihood of biologic utilization in Latinos compared to non-Latinos (Odds Ratio (OR) 2.4, 95% CI 1.1-5.4, p = .03). Independently, private insurance status is associated with increased biologic use compared to public insurance (OR 2.4, 95% CI 1.2-5.0, p = .02). Private insurance status did not differ between Latinos and non-Latinos with psoriasis (OR 1.0, 95% CI 0.5-1.9, p = .98). Conclusions Hispanic/Latino ethnicity and private insurance status are independent predictors of biologic utilization, suggesting that biologic mechanisms may influence the increased use of biologics in Latinos with psoriasis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|